Possible causes for the low prevalence of pediatric urolithiasis

Urology

Volumn 53, Issue 6, 1999, Pages 1229-1234

  Miyake, Osamu ^a   Yoshimura, Kazuhiro ^b   Tsujihata, Masao ^b   Yoshioka, Toshiaki ^b   Koide, Takuo ^b   Takahara, Shiro ^b   Okuyama, Akihiko ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRIC ACID; CREATININE; GLYCOSAMINOGLYCAN; MAGNESIUM; OXALIC ACID; PHOSPHORUS; URIC ACID;

ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN; MACROMOLECULE; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; URINE PH; URINE VOLUME; UROLITHIASIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CALCIUM OXALATE; CHILD; CHILD, PRESCHOOL; CRYSTALLIZATION; HUMANS; MALE; PREVALENCE; URINARY CALCULI;

EID: 0033151935     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00004-7     Document Type: Article

References (25)

1. Atmani F, Lacour B, Drucke T, et al: Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization. Urol Res 21: 61-66, 1993.
2. Atmani F, Lacour B, Jungers P, et al: Reduced inhibitory activity of uronic-acid-rich protein (UAP) in the urine of stone formers. Urol Res 22: 257-260, 1994.
3. Fleisch H: Inhibitors and promoters of stone formation. Kidney Int 13: 361-371, 1978.
4. Nikkila M, Koivula T, and Jokela H: Urinary citrate excretion in patients with urolithiasis and normal subjects. Fur Urol 16: 382-385, 1989.
5. Robertson WG, and Peacock M: Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin Sci 43: 499-506, 1972.
6. Robertson WG, Peacock M, Heyburn PJ, et al: Risk factors in calcium stone disease of the urinary tract. Br J Urol 50: 449-454, 1978.
7. Ryall RL: Glycosaminoglycans, proteins, and stone formation: adult themes and child's play. Pediatr Nephrol 10: 656-666, 1996.
8. Polinsky MS, Kaiser BA, and Baluarte HJ : Urolithiasis in childhood. Pediatr Clin North Am 34: 683-710, 1987.
9. Reiner RJ, Kroovand RL, and Perlmutter AD: Unusual aspects of urinary calculi in children. J Urol 121: 480-481, 1979.
10. Miyake O, Yoshimura K, Yoshioka T, et al: High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis. Urol Res 26: 209-213, 1998.
11. Jong JGN, Weavers RA, and Sambeek RL: Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethyleneblue. Clin Chem 38: 803-807, 1992.
12. Tawashi R, Consineau M, and Denis G: Calcium oxalate crystal growth in normal urine: role of contraceptive hormones. Urol Res 12: 7-9, 1984.
13. Robertson WG, Peacock M, and Nordin BEC: Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43: 31-37, 1973.
14. Yoshida T: Studies on calcium oxalate crystallization-propensity in human urine. (1) Basal studies for the measurement using an aggregometer. Jpn J Urol 78: 1693-1700, 1987.
15. Yoshida T: Studies on calcium oxalate crystallization-propensity in human urine. (2) Clinical studies using an aggregometer. Jpn J Urol 78: 1701-1706, 1987.
16. Ebisuno S, Miyata K, Kohjimoto Y, et al: Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer. Jpn J Urol 84: 339-344, 1993.
17. Hess B, Nakagawa Y, and Coe FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257: F99-F106, 1989.
18. Hess B: Tamm-Horsfall glycoprotein - inhibitor or promoter of calcium oxalate monohydrate crystallization process? Urol Res 20: 83-86, 1992.
19. Hess B: Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20: 393-398, 1994.
20. Koide T, Takemoto M, Itatani H, et al: Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. Invest Urol 18: 382-386, 1981.
21. Kok DJ, Papapoulos SE, and Bijvolet OLM: Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int 37: 51-56, 1990.
22. Michelacci YM, Glashan RQ, and Schor N: Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int 36: 1022-1028, 1989.
23. Nikkila MT: Urinary glycosaminoglycan excretion in normal and stone forming subjects: significant disturbance in recurrent stone formers. Urol Int 44: 157-159, 1989.
24. Yamaguchi S, Yoshioka T, Utsunomiya M, et al: Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol Res 21: 187-192, 1993.
25. Suzuki K, and Ryall RL: The effect of heparan sulfate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine. Br J Urol 78: 15-21, 1996.